17 / 48
17
WFSBP 2017
WFSBP Task Force Workshops, Symposia
/ Preliminary Scientific Programme
TFW-03-003
The WFSBP Treatment guideline for mixed states-
evidence and recommendations
Heinz Grunze, United Kingdom
TFW-03-004
What the CINP guideline recommends in mixed states
Konstantinos Fountoulakis, Greece
Symposia
aa
Sunday, 18 June 2017
T2: ANTIDEPRESSANTS: BASIC/CLINICAL
S-01
08:30–10:00
Towards novel rapid-acting antidepressants
Chair:
Tomi Rantamäki, Finland
Co-Chair: Gregers Wegener, Denmark
S-01-001
Rapid acting antidepressants in chronic pain
Ipek Yalcin, France
S-01-002
Morphological and structural alterations following rapid
acting antidepressants
Gregers Wegener, Denmark
S-01-003
Antidepressant potential of cannabidiol: Preclinical
evidence
Sâmia Joca, Brazil
S-01-004
Anesthetics as rapid-acting antidepressants
Tomi Rantamäki, Finland
T20: LIAISON PSYCHIATRY
S-02
08:30–10:00
Psychiatric services in emergency departments:
Challenges and solutions
Chair:
Ruby Castilla-Puentes, USA
Co-Chair: Tatiana Falcone, USA
S-02-001
Psychiatric consultations in rural general hospitals –
Latinos vs. Anglos
Bernardo Ng, USA
S-02-002
A study of insomnia and cormobid psychiatric condi-
tions in rehabilitation clinics
Franklin Escobar, Colombia
S-02-003
Depression and medical comorbidity in emergency
departments in Mexico
Ricardo Secin, Mexico
S-02-004
Self-inflicted injuri in children and adolescents: A study
in a tertiary care hospital in Santiago de Chile
Arturo Grau, Chile
T1: ADDICTIVE DISORDERS
S-03
08:30–10:00
Dissecting the role of the neurotrophin Brain Derived
Neurotrophic Factor in cocaine addiction: Clues from
clinical and preclinical studies
Chair:
Fabio Fumagalli, Italy
S-03-001
Acute exposure to cocaine during brain development
evokes depressive-like behaviors via downregulation of
Brain Derived Neurotrophic Factor signaling
Fabio Fumagalli, Italy
S-03-002
Cocaine and orbitofrontal cortical Brain Derived
Neurotrophic Factor deficiency induce habit-based
decision-making: Blockade by trkB stimulation
Shannon Gourley, USA
S-03-003
Systemic administration of the brain-penetrant TrkB
antagonist cyclotraxin-b reduces short and long access
cocaine intake
Michel Verheij, The Netherlands
S-03-004
Brain Derived Neurotrophic Factor and cocaine in clini-
cal samples: A useful biomarker for treatment?
Lisia von Diemen, Brazil
T6: BIPOLAR DISORDERS: BASIC/CLINICAL
S-04
10:15–11:45
Pathways of neuroprogression in Bipolar Disorder (BP)
Chair:
Benicio Frey, Canada
Co-Chair: Flavio Kapczinski, Brazil
S-04-001
Indicators or risk and resilience in the high-risk
offspring of bipolar parents
Anne Duffy, Canada
WED SUN